Medtronic (MDT) revenue +2% to $4.1B, or +3% at constant currency rates (CCR).
Net profit +12% to $953M.
International revenue +9% at CCR to $1.89B, +6% as reported, and accounts for 46% of total; emerging markets revenue +15% to $504M, or 12% of total.
Reiterates FY 2014 outlook: EPS of +6-8% to $3.80-3.85 vs consensus of 3.84; and CCR revenue growth of 3-4%. (Previous) (PR)